AAV-mediated delivery of CRISPR/Cas9 restored dystrophin expression to up to 90% of the normal level in some skeletal muscles of DMD dogs, while in cardiac muscle, dystrophin level reached 92%.189. This evidence concerns the gene DMD and Duchenne muscular dystrophy.